Financhill
Buy
52

DAWN Quote, Financials, Valuation and Earnings

Last price:
$9.61
Seasonality move :
-22.78%
Day range:
$9.51 - $9.82
52-week range:
$5.64 - $13.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.37x
P/B ratio:
2.19x
Volume:
931.1K
Avg. volume:
2.9M
1-year change:
-24.23%
Market cap:
$985.7M
Revenue:
$131.2M
EPS (TTM):
-$1.49

Earnings Data

Next earnings date for DAWN
Feb 24
2026
Most recent earnings per share
-$0.19
Beat by $0.09
(Nov 4/2025)
Consensus Estimate
-$0.28
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DAWN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/24/2026 Q4 $44.1M -- -- -$0.20 --
11/04/2025 Q3 $37.8M $39.8M -$0.19 -$0.28 $0.09
08/05/2025 Q2 $34.9M $33.9M -$0.29 -$0.34 $0.05
05/06/2025 Q1 $30.3M $30.8M -$0.35 -$0.44 $0.09
02/25/2025 Q4 $27.8M $29.2M -$0.65 -$0.35 -$0.30
10/30/2024 Q3 $28.5M $93.8M $0.38 -$0.25 $0.64
07/30/2024 Q2 $912.2K $8.2M -$0.05 -$0.59 $0.54
05/06/2024 Q1 -- -- -$0.72 -$0.66 -$0.06
02/26/2024 Q4 -- -- -$0.62 -$0.57 -$0.06
11/06/2023 Q3 -- -- -$0.54 -$0.58 $0.04
08/07/2023 Q2 -- -- -$0.61 -- --
05/01/2023 Q1 -- -- -$0.59 -- --
03/06/2023 Q4 -- -- -$0.55 -- --
11/07/2022 Q3 -- -- -$0.53 -- --
08/04/2022 Q2 -- -- -$0.60 -- --
05/12/2022 Q1 -- -- -$0.48 -- --
03/07/2022 Q4 -- -- -$0.35 -- --
11/08/2021 Q3 -- -- -$0.31 -- --
08/10/2021 Q2 -- -- -$1.85 -- --
03/31/2021 Q1 -- -- -$0.25 -- --
12/31/2020 Q4 -- -- -$0.82 -- --
09/30/2020 Q3 -- -- -$0.05 -- --
06/30/2020 Q2 -- -- -$0.03 -- --
03/31/2020 Q1 -- -- -$0.02 -- --
12/31/2019 Q4 -- -- $0.10 -- --
09/30/2019 Q3 -- -- $0.49 -- --
06/30/2019 Q2 -- -- -$0.05 -- --
03/31/2019 Q1 -- -- $0.66 -- --
12/31/2018 Q4 -- -- $0.11 -- --
09/30/2018 Q3 -- -- $0.36 -- --
06/30/2018 Q2 -- -- $0.06 -- --

Day One Biopharmaceuticals, Inc. Earnings Questions

  • How Much did Day One Biopharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Day One Biopharmaceuticals, Inc. reported $39.8M worth of top line sales in its most recent quarter.

  • Did Day One Biopharmaceuticals, Inc. Beat Earnings Last Quarter?

    Day One Biopharmaceuticals, Inc. announced earnings per share of -$0.19 which represents a beat of analyst forecast a -$0.28 per share.

  • Is Day One Biopharmaceuticals, Inc. Profitable?

    Day One Biopharmaceuticals, Inc. reported $35.3M that represents $0.34 per share over the last quarter.

  • What is the Analyst Consensus for Day One Biopharmaceuticals, Inc. EPS Next Year?

    Day One Biopharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.02 per share to -$0.67 per share next year representing a decrease of -5.04%.

  • When is Day One Biopharmaceuticals, Inc.'s Earnings Date?

    Day One Biopharmaceuticals, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock